Clinical Trials on Fallopian Cancer in Korea, Republic of
Total 3620 results
-
Korean Gynecologic Oncology GroupUnknownOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CancerKorea, Republic of
-
Asan Medical CenterRecruitingCervical Cancer | Ovarian Cancer | Fallopian Tube Cancer | Endometrial Cancer | Peritoneal CancerKorea, Republic of
-
Yonsei UniversityRecruitingFallopian Tube Cancer | Primary Peritoneal Cancer | Mucinous Ovarian CancerKorea, Republic of
-
Seoul National University HospitalRecruitingFallopian Tube Cancer | Peritoneal Cancer | Ovarian Cancer Stage IIIC | Ovarian Cancer Stage IVKorea, Republic of
-
The Catholic University of KoreaKorean Cancer Study GroupCompletedOvarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CancerKorea, Republic of
-
Yonsei UniversityCanariaBio Inc.RecruitingPARP Inhibitor Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients Not Candidate for Platinum RetreatmentKorea, Republic of
-
Asan Medical CenterBaxter Healthcare CorporationCompletedCervical Cancer | Gynecologic Cancer | Ovarian Cancer | Endometrial Cancer | Fallopian Tubal CancerKorea, Republic of
-
Seoul National University HospitalBoryung Pharmaceutical Co., LtdActive, not recruitingOvarian Cancer | Fallopian Tube Cancer | Recurrent Ovarian Carcinoma | Chemotherapy-induced Peripheral Neuropathy | Primary Peritoneal CarcinomaKorea, Republic of
-
Seoul National University HospitalPharos iBio Co., Ltd.RecruitingPlatinum-resistant Ovarian Cancer | Platinum-Resistant Fallopian Tube Carcinoma | Platinum-Resistant Primary Peritoneal Carcinoma | Platinum-refractory Ovarian CarcinomaKorea, Republic of
-
Shanghai Gynecologic Oncology GroupRecruitingFallopian Tube Cancer | Epithelial Ovarian Cancer | Primary Peritoneal CarcinomaKorea, Republic of, China
-
Samsung Medical CenterCompletedColorectal CancerKorea, Republic of
-
Samsung Medical CenterCompleted
-
Gangnam Severance HospitalSeoul National UniversityRecruitingBreast Cancer | HER2-negative Breast Cancer | Estrogen Receptor Positive Tumor | Premenopausal Breast Cancer | Node-positive Breast CancerKorea, Republic of
-
Samsung Medical CenterCompletedRefractory CancerKorea, Republic of
-
Seoul National University HospitalCompletedBile Duct Cancer | Ampulla of Vater Cancer | Periampullary Cancers With Obstructive Jaundice | Pancreas Head CancerKorea, Republic of
-
Korea Cancer Center HospitalCompletedCervical CancersKorea, Republic of
-
Asan Medical CenterRecruitingSubjects With Resectable and Localized Gastric Cancer | Subjects With Resectable Esophageal Cancer or Liver Cancer | Subjects With Resectable Liver CancerKorea, Republic of
-
Samyang Biopharmaceuticals CorporationRecruitingBreast Cancer | Head and Neck Cancer | Gastric Cancer | Esophageal Cancer | Ovarian Cancer | Prostate Cancer | Non-small Cell Lung CancerKorea, Republic of
-
National Cancer Center, KoreaJanssen Korea, Ltd., KoreaCompletedCancers, PainKorea, Republic of
-
Yonsei UniversityRecruiting
-
Seoul National University HospitalEulji University Hospital; Dongguk University Medical CenterRecruiting
-
Se Jun ParkRecruiting
-
Samsung Medical CenterActive, not recruiting
-
Samsung Medical CenterSeoul St. Mary's Hospital; Asan Medical Center; Chonnam National University Hospital and other collaboratorsRecruitingRectal Cancer | Rectosigmoid Cancer | Rectosigmoid Junction CancerKorea, Republic of
-
Yonsei UniversityUnknown
-
Seoul National University HospitalAsan Medical Center; Ulsan University Hospital; Korea University Anam Hospital; Ewha Womans University Mokdong Hospital and other collaboratorsCompletedAdvanced CancerKorea, Republic of
-
Yonsei UniversityCompletedPancreaticobiliary CancerKorea, Republic of
-
Seoul National University HospitalUnknown
-
Genomictree, Inc.Severance HospitalCompletedHealthy | Colorectal Cancer | Polyps | Other CancersKorea, Republic of
-
Korean Cancer Study GroupUnknownPhase II Study of Herzuma® Plus Gedatolisib in Patients With HER-2 Positive Metastatic Breast CancerMetastatic Breast Cancer | HER2-positive Breast CancerKorea, Republic of
-
Seoul National University HospitalCompleted
-
Seoul National University HospitalActive, not recruitingHormone Receptor-positive Breast Cancer | Premenopausal Breast CancerKorea, Republic of
-
Seoul National University HospitalActive, not recruitingInvasive Breast Cancer | Estrogen Receptor Positive Breast CancerKorea, Republic of
-
Mundipharma Korea LtdCompletedCancerKorea, Republic of
-
ImmuneOncia Therapeutics Inc.RecruitingAdvanced CancerKorea, Republic of
-
Yonsei UniversityRecruitingAdvanced CancerKorea, Republic of
-
Dong-A University HospitalCompletedColorectal Cancer | Pancreatic Cancer | Non-small Cell Lung CancerKorea, Republic of
-
National Evidence-Based Healthcare Collaborating...UnknownEarly Gastric Cancer | Endoscopic Submucosal Dissection | Multi-center, Single-arm Clinical Trial | Historical Control Group | Quality of Life and Cost AnalysisKorea, Republic of
-
Yonsei UniversityRecruitingPancreaticobiliary CancerKorea, Republic of
-
Aston Sci. Inc.Active, not recruiting
-
Samyang Biopharmaceuticals CorporationUnknownGynecologic CancerKorea, Republic of
-
Seoul National University HospitalJW PharmaceuticalCompletedInflammatory Bowel Diseases | Gastric Cancer | Pancreatic Cancer | Peptic Ulcer | Colon Cancer | Duodenal Cancer | Biliary CancerKorea, Republic of
-
Gangnam Severance HospitalActive, not recruitingPaancreatic CancerKorea, Republic of
-
National Cancer Center, KoreaActive, not recruitingMetastatic Breast Cancer | HER2-positive Breast CancerKorea, Republic of
-
Samsung Medical CenterActive, not recruitingTriple Negative Breast Cancer | HER2-positive Breast CancerKorea, Republic of
-
Yonsei UniversityRecruitingHealthy Volunteer | Invasive CancerKorea, Republic of
-
Yonsei UniversityRecruitingMetastatic Breast Cancer | HER2-positive Breast Cancer | PostmenopausalKorea, Republic of
-
Samsung Medical CenterActive, not recruitingAdvanced, Refractory CancerKorea, Republic of
-
Samsung Medical CenterCompletedGenitourinary Cancer | Metastatic Gastrointestinal CancerKorea, Republic of